Healthway: Peter Lim sold down his stake from 7.2% to 4.9% on 14 Oct. Now you know the real reason for the share price weakness. We have strongly hinted earlier that a key sh/h does not see eye to eye with the company's expansion plans in China.
The posts on this site, including but not limited to images, links, and comments left by readers, do not necessarily represent Maybank Kimeng Securities Pte Ltd positions, strategies or opinions.
All information herein are published for general information. Reader should not rely solely on the information published and should seek independent financial advice prior to making any investment decision. The publisher accepts no liability for any loss whatsoever arising from any use of the information published herein.